Shanghai Serum Bio-Technology Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 6/6
Shanghai Serum Bio-Technology has a total shareholder equity of CN¥1.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.1B and CN¥31.3M respectively. Shanghai Serum Bio-Technology's EBIT is CN¥48.4M making its interest coverage ratio -4.1. It has cash and short-term investments of CN¥851.9M.
Wichtige Informationen
0%
Verhältnis von Schulden zu Eigenkapital
CN¥0
Verschuldung
| Zinsdeckungsgrad | -4.1x |
| Bargeld | CN¥851.87m |
| Eigenkapital | CN¥1.11b |
| Gesamtverbindlichkeiten | CN¥31.33m |
| Gesamtvermögen | CN¥1.15b |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 688163's short term assets (CN¥968.1M) exceed its short term liabilities (CN¥21.8M).
Langfristige Verbindlichkeiten: 688163's short term assets (CN¥968.1M) exceed its long term liabilities (CN¥9.5M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 688163 is debt free.
Schulden abbauen: 688163 had no debt 5 years ago.
Schuldendeckung: 688163 has no debt, therefore it does not need to be covered by operating cash flow.
Zinsdeckung: 688163 has no debt, therefore coverage of interest payments is not a concern.